Recombinant respiratory syncytial virus pre-fusion F protein vaccine

Description

In this Product Explainer, Infectious Disease Physician and Microbiologist Prof Paul Griffin explains the role of a recombinant respiratory syncytial virus pre-fusion F protein vaccine for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Jeremy Grummet

A/Prof Jeremy Grummet

PSA Testing Demystified

Clinical A/Prof Lauren Sanders

Clinical A/Prof Lauren Sanders

Migraine Management Update

Dr Johanna Lynch

Dr Johanna Lynch

Trauma-Informed Care in GP

Prof Richard O'Brien

Prof Richard O'Brien

Prevention and Management of Diabetic Retinopathy

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Paul Griffin

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland

Date published: 29 October 2024